Request Info


Ask for our annual reports or more information
Email Us

Email Alerts

Sign up for email alerts
Email Alerts
Investor Relations

News Release

RSS RSS Feeds
Printer Friendly Version View printer-friendly version
<< Back
Meridian Bioscience to Present at Friedman, Billings, Ramsey & Co. 2005 Washington Conference

CINCINNATI, Mar 1, 2005 (BUSINESS WIRE) -- Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that the Company has been invited to present at the Friedman, Billings, Ramsey & Co. 2005 Washington Conference on Thursday, March 3, 2005 at 2:20 p.m. EST at the Mandarin Oriental Washington in Washington, D.C. The Conference will feature presentations from companies representing Homeland Security, Defense and Government IT. Jack Kraeutler, President and Chief Operating Officer, is scheduled to present. A question and answer session will follow and some of the information provided during the session may not have been previously disclosed.

Meridian invites investors to listen to management's remarks, over the internet, on the Company's website at www.meridianbioscience.com. The archived broadcast will be available for 90 days.

Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, and respiratory infections. Meridian diagnostic products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents and specialty biologicals along with proteins and other biologicals used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices and diagnostics manufacturers in more than 60 countries around the world. The Company's shares are traded through Nasdaq's National Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.

SOURCE: Meridian Bioscience, Inc.

Meridian Bioscience, Inc.
John A. Kraeutler, 513-271-3700